Prognostic value of C-reactive protein, leukocytes, and vitamin D in severe chronic obstructive pulmonary disease

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Moberg, Mia ^a   Vestbo, Jørgen ^b,c   Martinez, Gerd ^a   Lange, Peter ^a,d   Ringbaek, Thomas ^a  

^a HVIDOVRE HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; VITAMIN D;

AGED; BLOOD; FEMALE; HOSPITALIZATION; HUMAN; LEUKOCYTE COUNT; MALE; METABOLISM; MIDDLE AGED; MORTALITY; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTOR; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HOSPITALIZATION; HUMANS; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; VITAMIN D;

EID: 84893821980     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/140736     Document Type: Article

References (33)

1. Agusti A. G. N., COPD, a multicomponent disease: implications for management. Respiratory Medicine 2005 99 6 670 682 2-s2.0-18244367647 10.1016/j.rmed.2004.11.006 (Pubitemid 40631293)
2. Rosenberg S. R., Kalhan R., Biomarkers in chronic obstructive pulmonary disease. Translational Research 2012 159 4 228 237 2-s2.0-84858385254 10.1016/j.trsl.2012.01.019
3. Gan W. Q., Man S. F. P., Senthilselvan A., Sin D. D., Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 2004 59 7 574 580 2-s2.0-3142517968 10.1136/thx.2003.019588 (Pubitemid 38901515)
4. Dahl M., Vestbo J., Lange P., Bojesen S. E., Tybjærg-Hansen A., Nordestgaard B. G., C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2007 175 3 250 255 2-s2.0-33846785205 10.1164/rccm.200605-713OC (Pubitemid 46203128)
5. Thomsen M., Dahl M., Lange P., Vestbo J., Nordestgaard B. G., Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2012 186 10 982 988 10.1164/rccm.201206-1113OC
6. Melamed M. L., Michos E. D., Post W., Astor B., 25-hydroxyvitamin D levels and the risk of mortality in the general population. Archives of Internal Medicine 2008 168 15 1629 1637 2-s2.0-49449104636 10.1001/archinte.168.15.1629
7. Skaaby T., Husemoen L. L., Pisinger C., Vitamin D status and cause-specific mortality: a general population study. PLoS ONE 2012 7 12 e52423 10.1371/journal.pone.0052423
8. Janssens W., Bouillon R., Claes B., Carremans C., Lehouck A., Buysschaert I., Coolen J., Mathieu C., Decramer M., Lambrechts D., Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010 65 3 215 220 2-s2.0-77949784497 10.1136/thx.2009.120659
9. Vestbo J., Rennard S., Chronic obstructive pulmonary disease biomarker(s) for disease activity needed-urgently. American Journal of Respiratory and Critical Care Medicine 2010 182 7 863 864 2-s2.0-77958159129 10.1164/rccm.201004-0602ED
10. Williams J. E. A., Green R. H., Warrington V., Steiner M. C., Morgan M. D. L., Singh S. J., Development of the i -BODE: validation of the incremental shuttle walking test within the BODE index. Respiratory Medicine 2012 106 3 390 396 2-s2.0-84855886866 10.1016/j.rmed.2011.09.005
11. Celli B. R., Cote C. G., Marin J. M., Casanova C., Montes De Oca M., Mendez R. A., Plata V. P., Cabral H. J., The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. The New England Journal of Medicine 2004 350 10 1005 1012 2-s2.0-1442306237 10.1056/NEJMoa021322 (Pubitemid 38269277)
12. Ong K.-C., Earnest A., Lu S.-J., A multidimensional grading system (BODE index) as predictor of hospitalization for COPD. Chest 2005 128 6 3810 3816 2-s2.0-30344451939 10.1378/chest.128.6.3810 (Pubitemid 43062640)
13. Marin J. M., Carrizo S. J., Casanova C., Martinez-Camblor P., Soriano J. B., Agusti A. G. N., Celli B. R., Prediction of risk of COPD exacerbations by the BODE index. Respiratory Medicine 2009 103 3 373 378 2-s2.0-59349095038 10.1016/j.rmed.2008.10.004
14. Singh S. J., Morgan M. D., Scott S., Walters D., Hardman A. E., Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992 47 12 1019 1024 2-s2.0-0027089979 (Pubitemid 23011018)
15. Thomsen M., Ingebrigtsen T., Marott J., Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease. The Journal of the American Medical Association 2013 309 22 2353 2361 10.1001/jama.2013.5732
16. Agusti A., Edwards L. D., Rennard S. I., Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS ONE 2012 7 5 e37483 10.1371/journal.pone.0037483
17. Celli B. R., Locantore N., Yates J., Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. American Journal of Respiratory and Critical Care Medicine 2012 185 10 1065 1072 10.1164/rccm.201110-1792OC
18. Garcia-Polo C., Alcazar-Navarrete B., Ruiz-Iturriaga L. A., Factors associated with high healthcare resource utilisation among COPD patients. Respiratory Medicine 2012 106 12 1734 1742 10.1016/j.rmed.2012.09.009
19. Gaki E., Kontogianni K., Papaioannou A. I., Bakakos P., Gourgoulianis K. I., Kostikas K., Alchanatis M., Papiris S., Loukides S., Associations between BODE index and systemic inflammatory biomarkers in COPD. COPD: Journal of Chronic Obstructive Pulmonary Disease 2011 8 6 408 413 2-s2.0-83155191784 10.3109/15412555.2011.619599
20. Liu S.-F., Wang C.-C., Chin C.-H., Chen Y.-C., Lin M.-C., High value of combined serum C-reactive protein and BODE score for mortality prediction in patients with stable COPD. Archivos de Bronconeumologia 2011 47 9 427 432 2-s2.0-80052462598 10.1016/j.arbres.2011.04.011
21. Man S. F., Connett J. E., Anthonisen N. R., Wise R. A., Tashkin D. P., Sin D. D., C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 2006 61 10 849 853 2-s2.0-33749998694 10.1136/thx.2006.059808 (Pubitemid 44570304)
22. de Torres J. P., Cordoba-Lanus E., López-Aguilar C., Muros de Fuentes M., Montejo de Garcini A., Aguirre-Jaime A., Celli B. R., Casanova C., C-reactive protein levels and clinically important predictive outcomes in stable COPD patients. European Respiratory Journal 2006 27 5 902 907 2-s2.0-33845371349 10.1183/09031936.06.00109605 (Pubitemid 44911101)
23. de Torres J. P., Pinto-Plata V., Casanova C., Mullerova H., Córdoba-Lanús E., Muros De Fuentes M., Aguirre-Jaime A., Celli B. R., C-reactive protein levels and survival in patients with moderate to very severe COPD. Chest 2008 133 6 1336 1343 2-s2.0-45949086220 10.1378/chest.07-2433 (Pubitemid 351892988)
24. Karadag F., Kirdar S., Karul A. B., Ceylan E., The value of C-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. European Journal of Internal Medicine 2008 19 2 104 108 2-s2.0-39049147868 10.1016/j.ejim.2007.04.026
25. Dickens J. A., Miller B. E., Edwards L. D., Silverman E. K., Lomas D. A., Tal-Singer R., COPD association and repeatability of blood biomarkers in the ECLIPSE cohort. Respiratory Research 2011 12, article 146 2-s2.0-80155137352 10.1186/1465-9921-12-146
26. Holmgaard D. B., Mygind L. H., Titlestad I. L., Serum vitamin D in patients with chronic obstructive lung disease does not correlate with mortality-results from a 10-year prospective cohort study. PLoS ONE 2013 8 1 e53670 10.1371/journal.pone.0053670
27. Hutchinson M. S., Grimnes G., Joakimsen R. M., Figenschau Y., Jorde R., Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromsø study. European Journal of Endocrinology 2010 162 5 935 942 2-s2.0-77951656788 10.1530/EJE-09-1041
28. Ginde A. A., Scragg R., Schwartz R. S., Camargo C. A. Jr., Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older U.S. adults. Journal of the American Geriatrics Society 2009 57 9 1595 1603 2-s2.0-69549133632 10.1111/j.1532-5415.2009.02359.x
29. Ringbaek T., Martinez G., Durakovic A., Thøgersen J., Midjord A.-K., Jensen J.-E. B., Lange P., Vitamin D status in patients with chronic obstructive pulmonary disease who participate in pulmonary rehabilitation. Journal of Cardiopulmonary Rehabilitation and Prevention 2011 31 4 261 267 2-s2.0-79960847323 10.1097/HCR.0b013e31821c13aa
30. Black P. N., Scragg R., Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination Survey. Chest 2005 128 6 3792 3798 2-s2.0-30344488982 10.1378/chest.128.6.3792 (Pubitemid 43062638)
31. Ginde A. A., Mansbach J. M., Camargo C. A. Jr., Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the third national health and nutrition examination survey. Archives of Internal Medicine 2009 169 4 384 390 2-s2.0-61449136072 10.1001/archinternmed.2008.560
32. Lehouck A., Mathieu C., Carremans C., Baeke F., Verhaegen J., van Eldere J., Decallonne B., Bouillon R., Decramer M., Janssens W., High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Annals of Internal Medicine 2012 156 2 105 114 2-s2.0-84855832483
33. Pludowski P., Holick M. F., Pilz S., Vitamin D effects on musculoskeletal health, immunity, autoimmunity, cardiovascular disease, cancer, fertility, pregnancy, dementia and mortality-a review of recent evidence. Autoimmunity Reviews 2013 12 10 976 989 10.1016/j.autrev.2013.02.004